Mymetics Corp - Company Profile

Powered by

All the data and insights you need on Mymetics Corp in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Mymetics Corp Strategy Report

  • Understand Mymetics Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Mymetics Corp: Overview

Select Item

Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for life disabling and infectious diseases. The company develops pipeline products based on its proprietary technology platform virosomes with the utilization of rationally designed antigens, natural membrane proteins and lipid based carrier with fusion viral proteins. Its pipeline product includes vaccine candidates that target HIV-1/AIDS, chikungunya, intra nasal influenza, malaria, herpes simplex virus (HSV), and respiratory syncytial virus (RSV). Mymetics vaccines are designed for protection against early transmission and infection. The company has its subsidiaries in the Netherlands and Switzerland. Mymetics is headquartered in Epalinges, Switzerland.

 Gain a 360-degree view of Mymetics Corp and make more informed decisions for your business Gain a 360-degree view of Mymetics Corp and make more informed decisions for your business Find out more
Headquarters Switzerland
Address Route De La Corniche 4, Epalinges, 1066
Website www.mymetics.com
Telephone 41 21 6534535
No of Employees 8
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange MYMX (OTC)
Revenue (2022) $1.1M 139.1% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -1.6% (2022 vs 2021)
Net Profit Margin (2022) XYZ 57.5% (2022 vs 2021)
   
* As of and is in US$
View Mymetics Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Mymetics Corp premium industry data and analytics

17+

Pipeline Drugs

Identify which of Mymetics Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

6

Clinical Trials

Determine Mymetics Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

3

Catalyst Calendar

Proactively evaluate Mymetics Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products
Pipeline
Phase I:
Malaria Vaccine
XYZ
XYZ
XYZ
Understand Mymetics Corp portfolio and identify potential areas for collaboration Understand Mymetics Corp portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Mymetics Corp Merck & Co Inc GSK plc Novavax Inc Crucell Holland BV
Headquarters Switzerland United States of America United Kingdom United States of America Netherlands
City Epalinges Kenilworth Brentford Gaithersburg Leiden
State/Province - New Jersey England Maryland Zuid-Holland
No. of Employees 8 69,000 69,400 1,992 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ronald Kempers Chief Financial Officer; Chief Executive Officer; President Senior Management 2012 55
Sylvain Fleury Chief Scientific Officer Senior Management 2003 -
Mario Amacker, Ph.D. Head - Quality and Manufacturing Senior Management - -
Ulrich Burkhard Director Non Executive Board - 62
Thomas Staehelin Director Non Executive Board - 75
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Mymetics Corp key executives to enhance your sales strategy Gain insight into Mymetics Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code